Novavax, Inc. (NASDAQ:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced the appointment …
Recently, various executives have taken part in insider selling activity for the stocks of Avalanche Biotechnologies Inc (NASDAQ:AAVL), Novavax, Inc. (NASDAQ:NVAX), Yelp Inc …
Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Twitter Inc (NYSE:TWTR), …
MLV analyst Vernon Bernardino came out today with a favorable report on Novavax, Inc. (NASDAQ:NVAX), as Fast Track designation was given by the FDA to MEDI-8897, a …
J.P.
In a research report issued today, J.P.
In a research note released today, MLV analyst George Zavoico reiterated a Buy rating on Novax (NASDAQ:NVAX) with a $14 price target, following …
In a research note issued this morning, MLV analyst George Zavoico reiterated a Buy rating on Novavax (NASDAQ:NVAX) with a $14 price target, …